Cargando…
An Integrative Pharmacogenomic Approach Identifies Two-drug Combination Therapies for Personalized Cancer Medicine
An individual tumor harbors multiple molecular alterations that promote cell proliferation and prevent apoptosis and differentiation. Drugs that target specific molecular alterations have been introduced into personalized cancer medicine, but their effects can be modulated by the activities of other...
Autores principales: | Liu, Yin, Fei, Teng, Zheng, Xiaoqi, Brown, Myles, Zhang, Peng, Liu, X. Shirley, Wang, Haiyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768263/ https://www.ncbi.nlm.nih.gov/pubmed/26916442 http://dx.doi.org/10.1038/srep22120 |
Ejemplares similares
-
Pharmacogenomics in Personalized Medicine and Drug Metabolism
por: Chang, Wei-Chiao
Publicado: (2014) -
Towards pathway-centric cancer therapies via pharmacogenomic profiling analysis of ERK signalling pathway
por: Wang, Haiyun, et al.
Publicado: (2015) -
Pharmacogenomics and Personalized Medicine
por: Cecchin, Erika, et al.
Publicado: (2020) -
Pharmacogenomics: the promise of personalized medicine.
por: Hood, Ernie
Publicado: (2003) -
5. Pharmacogenomics and Personalized Medicine
por: Topić, Elizabeta
Publicado: (2008)